By targeting PCNA with ATX-101, an APIM-containing cell-penetrating peptide, we induced apoptosis in MM cell lines and primary cells, and increased the sensitivity against the chemotherapeutic melphalan. The gene discussed is PCNA; the disease is Miyoshi myopathy.